The power to propel your research

Discover the properties and dynamics of the immune repertoire with the quantitative power of the immunoSEQ® Assay.

Set your research in motion
  • immunoSEQ® HLA Classifier – Now Available!
    The immunoSEQ HLA Classifier infers human leukocyte antigen (HLA) type based on the T-cell receptor (TCR) profile, providing a subject’s HLA type and TCR sequence data from a single sample of blood or peripheral blood mononuclear cells (PBMCs).

    LEARN MORE

  • Infectious Disease Publication Review
    In this review, we focus on lessons learned from infectious disease research around viral infections and vaccine development, and immune response in HIV, TB, cytomegalovirus infection and more.

    READ MORE

  • ON DEMAND – Using immunosequencing to characterize HLA and its role in disease
    Human leukocyte antigen proteins (HLA) are essential players in immune function, and HLA type is increasingly linked to disease susceptibility. Watch our on-demand webinar to learn more.

    WATCH NOW

  • Quote Customization—Now Available!
    Choose from an array of assays and species to tailor your quote request and get started with immunoSEQ.

    REQUEST QUOTE

  • immunoSEQ® T-MAP™ COVID
    Get deep insights into the role of T cells in COVID-19 with applications in vaccine and therapeutic development.

    LEARN MORE

The gold standard of immunosequencing

immunoSEQ Technology provides a quantitative, end-to-end immunosequencing solution that helps you discover the breadth and depth of the adaptive immune system. From experimental design to publication ready data, this solution gives you the power to decipher the complexity of the adaptive immune system, providing fundamental insights into the body’s response to disease and therapy at the cellular level.

Learn more about Assays
ImmunoSEQ Web Home Cell
Heading 3 Accent Graphic
Rigor you can trust

In the rapidly expanding world of immunosequencing, turn to the proven technology that has been leveraged as a trusted solution and used in over 600 high-impact publications. We provide validated, reproducible immunosequencing results you can count on to drive your research forward.

Heading 3 Accent Graphic
Flexibility to Scale

immunoSEQ Technology has adaptability to support diverse research applications and needs. We offer flexibility through a wide variety of sample types, including FFPE tissue, access to our assays through our Service lab and dedicated support services to help optimize your experiments and navigate challenges.

immunoSEQ research applications

Our immunosequencing solution has the adaptability to support diverse research applications and needs. Including basic immunology, translational research, autoimmune disease, infectious disease, oncology, and much more. Explore how researchers around the world are using the immunoSEQ Assay to drive discoveries.

Explore

immunoSEQ® T-MAP™ COVID

Decode the T-cell response in COVID-19 with a comprehensive view of SARS-CoV-2 specific antigen and T-cell receptor (TCR) sequence level data combined with robust analytics tools. Study private vs public T-cell clones in COVID-19 and more.

Learn More
From data to discovery
immunoSEQ From Data To Discovery
immunoSEQ® Analyzer

Analyze immunosequencing data with sophisticated, yet easy to use data analysis tools, compare analysis from multiple investigators, and easily share your projects with colleagues and off-site collaborators.

immuneACCESS®

Dive into the world’s largest collection of T-cell receptor (TCR) and B-cell receptor (BCR) sequences with immuneACCESS. Construct your own projects, draw your own conclusions, and freely publish new discoveries.

Covid Icon Covid Icon
COVID-19 Applications

Learn how immunoSEQ® T-MAP™ COVID can help uncover the T-cell immune response in COVID-19.

Learn More
Library Icon Email Icon
Resources

Access technical documents for getting started with the immunoSEQ® Service product, grant writing support, and FAQs.

Learn More

This is text for the modal body

Please select your location to continue:

United States Outside the U.S.